capital

Portfolio Strategies of Life Science Venture Capital Firms in the USA and Europe

Motivated by the different development stages of both, the venture capital (VC) as well as the life science industry in the USA and Europe, the authors investigate portfolio strategies of US-American and European VC firms active in this sector. Results show that US life science VCs are equally likely to have a focus on early stage ventures and to diversify across investment stages as their European counterparts.

Limited Partnership Reform in the United Kingdom: A Competitive, Venture Capital Oriented Business Form

This paper evaluates the primary legal and financial mechanisms that help support the development of a venture capital market. Specifically, the authors argue that emulating the organization and contractual pattern of the U.S. venture capital market could enhance the development of the European venture capital market.

Why are Capital Flows so Much More Volatile in Emerging Than in Developed Countries?

The standard deviations of capital flows to emerging countries are 80 percent higher than those to developed countries, according to the author. Results suggest that underdevelopment of domestic financial markets, weak institutions, and low income per capita, are all associated with capital flow volatility.

Capital Inflows and Investment in Developing Countries

This paper has been prepared within the framework of the research project on globalization and employment. The focus is on manufacturing industries both because global restructuring of manufacturing industries is a central feature of globalization and because FDI inflows into developing countries in recent years have been mainly into manufacturing.